Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

B7-33, a synthetic analog of relaxin-2, has emerged as a focal point in contemporary scientific research due to its selective ...

Tribune’s lead candidate, TRX-44, mimics how CCN5 stops fibrosis signaling and is being developed first to treat the chronic lung disease idiopathic pulmonary fibrosis. The small team in Oslo ...

The B7-33 peptide, a derivative of the H2-relaxin hormone, has garnered attention in scientific research due to its potential ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...